OneSource Specialty Pharma Limited has successfully allotted 36,065 equity shares under its Employee Stock Option Plan 2021 to eligible employees. The Management Committee approved this allotment during its meeting held on January 21, 2026, marking another milestone in the company's employee incentive program.

Share Allotment Details

The allotment was executed under the OneSource Specialty Pharma Limited – Employee Stock Option Plan 2021 (ONESOURCE ESOP 2021), with employees exercising their vested options. The key parameters of this allotment are presented below:

Impact on Share Capital Structure

The allotment has resulted in an expansion of the company's equity base. The paid-up share capital witnessed an increase following the incorporation of these new shares:

Regulatory Compliance and Share Characteristics

The allotment was conducted in full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company had previously filed the required statement under Regulation 10(b) with stock exchanges on March 12, 2025.

The newly allotted equity shares carry the following characteristics:

• Rank pari passu with existing equity shares in all respects
• No lock-in restrictions applicable
• Identical to existing shares in terms of rights and privileges
• Listed on BSE Limited and National Stock Exchange of India Limited

Corporate Governance Framework

The allotment process was overseen by the Management Committee and executed under the supervision of Company Secretary and Compliance Officer Trisha A (Membership Number: A47635). The company maintains its registered office at Unit No. 902, "Cyber One", Plot No - 4 & 6, Sector 30A, Vashi, Navi Mumbai 400703, ensuring proper governance standards throughout the process.

This ESOP allotment reflects OneSource Specialty Pharma's commitment to employee participation in the company's growth story while maintaining strict adherence to regulatory requirements and corporate governance practices.

OneSource Specialty Pharma Limited has scheduled its earnings call for Saturday, January 24, 2026, at 09:30 AM IST to discuss the company's unaudited financial results for the quarter ended December 31, 2025. The pharmaceutical company announced this development through a regulatory filing dated January 19, 2026.

Earnings Call Schedule

The earnings call has been organized to provide analysts and investors with insights into the company's Q3FY26 performance. The call will be conducted on a Saturday morning, allowing participants to engage with the senior management team regarding the quarterly financial results.

Management Participation

The earnings call will feature key members of OneSource Specialty Pharma's senior management team who will interact with participants and address queries related to the company's quarterly performance.

Senior Management Speakers:

• Arun Kumar, Founder & Non-Executive Chairperson
• Neeraj Sharma, CEO & MD
• Anurag Bhagania, CFO

Conference Call Access Details

The company has provided multiple access options for participants to join the earnings call. Analysts and investors can use the universal access numbers or register early through the DiamondPass registration system.

Regulatory Compliance

The earnings call announcement was made in compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) regulations. The communication was signed by Trisha A, Company Secretary and Compliance Officer (Membership Number: A47635), ensuring proper regulatory adherence for the scheduled investor interaction.